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INTRODUCTION
Ankylosing spondylitis (AS) is found worldwide and more
often in Caucasians than in other races (1). It is recognized
that race, sex, and HLA B27 status are factors that may influ-
ence both the clinical presentation and course of the disease
(1). The precise role of racial and ethnic patterns in the clin-
ical feature is unknown. However, the association has been
explained by the different prevalence of HLA B27 (1). The
prevalence of HLA B27 among Koreans was reported to be
between 2.3 and 3% (1, 2). As there are marked differences
in the prevalence of AS among many racial and ethnic groups,
comparative studies involving different populations are nec-
essary to clarify the role of racial and ethnic patterns.
There have been studies on clinical features of AS depend-
ing upon the race and areas (3-5), but no study has been pub-
lished so far on the clinical spectrum of AS in Korea. The aim
of this study was to determine the symptom profile of AS.
Also, we analyzed the differences in the clinical manifesta-
tions according to the sex, the age of onset, the presence of
peripheral arthritis and the of HLA B27 status. 
MATERIALS AND METHODS
Patients
A total of 412 AS patients attending The Hospital for Rheu-
matic Diseases, Hanyang University from 1985 to 1999 were
studied retrospectively. The diagnosis of AS was given to those
who fulfilled the criteria of the modified New York criteria
(1). We excluded the patients with reactive arthritis, psoria-
sis, arthritis associated with inflammatory bowel disease and
undifferentiated spondyloarthropathy. Data were collected
retrospectively from the patients’ medical records, and we col-
lected the information or findings that might have been pre-
sent but were not recorded in the medical charts during fol-
low-up. We excluded those patients in whom sufficient infor-
mation was lacking.
Demographic data
Data on age, sex, age at symptom onset, symptom duration,
and onset and duration of inflammatory back pain were re-
corded. Age at symptom onset was defined as time when the
first symptom, whether it was axial symptom, peripheral
Ji-Hyun Lee, Jae-Bum Jun, Sungsoo Jung,
Sang-Cheol Bae, Dae-Hyun Yoo, 
Think-You Kim, Seong Yoon Kim, 
Tae-Hwan Kim
The Hospital for Rheumatic Diseases, Hanyang
University, Seoul, Korea
Address for correspondence
Tae-Hwan Kim, M.D.
The Hospital for Rheumatic Diseases, Hanyang
University, 17 Haengdang-dong, Sungdong-gu,
Seoul 133-792, Korea
Tel : +82.2-2290-9246, Fax : +82.2-2298-8231
E-mail : thkim@hanyang.ac.kr
669
J Korean Med Sci 2002; 17: 669-73
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Higher Prevalence of Peripheral Arthritis Among Ankylosing 
Spondylitis Patients
This study was performed to define the clinical spectrum and disease manifesta-
tions of ankylosing spondylitis (AS) in a referral hospital setting. We identified the
differences in clinical manifestations according to the sex, the age at onset, the
presence of peripheral arthritis and the presence of HLA B27. A total 412 patients
(357 males, 55 females) were recruited. Eighty-seven percent were men and 155
out of 412 patients (35%) were juvenile-onset. HLA B27 was detected in 385 pa-
tients (93%). Peripheral joint involvement was noted in 287 of total AS cases (juve-
nile-onset ankylosing spondylitis (JOAS), 82%; adult-onset ankylosing spondyli-
tis (AOAS), 61%), and was more common than those reported in other studies.
A greater portion of patients with JOAS had peripheral arthritis and peripheral en-
thesitis than the patients with AOAS. The patients with peripheral arthritis showed
a younger age at onset and an increased tendency of having enthesitis and trau-
ma history. The natural history of Korean AS appears largely similar to those
seen in Europe and North America, except a few differences. JOAS was quite
common and AS was about nine times more common in men than in women. In
addition, the HLA B27 antigen frequency was 93%, which is higher than those
reported in other studies.
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arthritis, or enthesitis, had developed. Symptom duration was
calculated by subtracting the year of symptom onset from
1999.
Clinical data
Patients were asked about family history (first-and second-
degree relatives) of spondyloarthropathies (SpA). All data were
recorded about the details of inflammatory back pain, periph-
eral arthritis, enthesitis, trauma, uveitis, dactylitis, oral ulcer,
and renal involvement. The determination of current or pre-
vious inflammatory back pain was made based on symptoms
persisting at least 3 months, improving with exercise and
worsening with rest. Peripheral arthritis was defined as the
presence of swelling and/or restricted range of motion in at
least one peripheral joint, and/or history of previous swelling
in at least one peripheral joint confirmed at that time by a
rheumatologist (not including hip or shoulder joints) (1).
Enthesitis was defined as inflammation and/or pain of periph-
eral entheses such as in calcaneal insertions of the Achilles
tendon, plantar fascia, tibial tuberosities, costosternal junc-
tion, iliac crest, and greater trochanter (1). Oral ulcer was de-
fined as ulcer on mucous membrane involvement of nose or
mouth. As emotional trauma is difficult to assess in a quan-
titative manner, we only included the direct physical trauma
that had occurred before the joint involvement. Dactylitis
was defined as diffuse digit swelling extending beyond the
margin of the joint capsule (1). Renal abnormality was con-
sidered when proteinuria, hematuria, impairment of renal
function, and other abnormalities on light microscopy were
seen. We identified the differences in clinical manifestations
according to the sex and the presence of peripheral arthritis.
Also, data from the juvenile-onset ankylosing spondylitis
(JOAS) (onset before the age of 16 yr) and adult-onset anky-
losing spondylitis (AOAS) (onset after the age of 16 yr) groups
were compared.
Laboratory data
Routine diagnostic laboratory tests (complete blood counts,
erythrocyte sedimentation rate, serum creatinine, urinalysis)
and rheumatoid factor (RF) by nephelometry (normal: <20
IU/mL) were done on every individuals and HLA-B27 status
was determined by microcytotoxicity method. Radiographs
including pelvis, lumbar spine, certain painful joints, and
chest were obtained. We compared the differences in clinical
manifestations according to the positivity of HLA B27.
Statistical analyses
Statistical analyses was performed using the SPSS statistical
package. Chi-square tests and t-tests for independent values
were used. p-value of <0.05 was regarded as significant. 
RESULTS
Overall outcome
During the study period, 412 were diagnosed with AS.
The clinical characteristics are shown in Table 1. The male-
to-female ratio in AS was about 9:1. One hundred and forty
five out of 412 patients had a juvenile onset. Two hundred
and eighty seven patients (70%) were found to have periph-
eral joint involvement. The most commonly affected joints
were knee (91%) and ankle (59%). The most common enthe-
sitis was Achilles tendinitis (n=191, 88%). Hematuria or
proteinuria was found in 24 patients of 395 (6%), and biop-
sy was done in 6 patients, all of whom were diagnosed with
IgA nephropathy. Two patients were found to have other con-
comitant connective tissue diseases, which were mixed con-
nective tissue disease and lupus, respectively (6). One patient
who suffered from severe diarrhea was diagnosed with intesti-
nal amyloidosis. No patient showed pulmonary fibrosis of
lung.
Distribution of initially-affected joints 
The sites initially involved were the axial joints including
hip and shoulder (53%), peripheral joints (36%), and enthe-
Sex, M/F
Age at onset, years
Duration of disease
AOAS/JOAS
Peripheral arthritis
Knee
Ankle
Small joint of feet
Elbow
Small joints of hand
Wrist
Hip
Shoulder
Enthesitis
Achilles tendon
Plantar fascitis
Tibial tubercle
Costosternal junction
Iliac crest
Greater trochanter
Family history of spondyloarthropathy
Trauma history
Uveitis
Renal involvement
Oral ulcers
Dactylitis
HLA B27
Rheumatoid factor
357 (55), 87 (13)
19.2±7.1
11.0±6.7 
267/145
287 (70)
262 (64)
170 (41)
71 (17)
63 (15)
53 (13)
41 (10)
248 (60)
121 (29) 
217 (53)
191 (88)
128 (31) 
119 (29) 
118 (28) 
95 (23)
81 (20)
58 (16)
44 (11)
91 (22)
24/395 (6)
40/356 (11)
4/406 (1)
385 (93)
50 (12)
Feature Cases (%)
Table 1. Clinical features of ankylosing spondylitis patientsses (11%), in decreasing order (Table 2). The axial joints that
were most commonly involved initially were the sacroiliac
joints (37%). The peripheral joint that was most commonly
affected initially was the knee (27%). 
Serologic findings
HLA B27 status was determined in all patients, and 385
(93%) were positive for HLA B27. All were serologically test-
ed for RF on one or more occasions with positive result in 50
cases (12%), but the titers were low.
Comparisons between male and female AS 
The mean age at disease onset was 18.8±6.9 yr in men,
and 22.2±8.0 yr in women (Table 3). Considering only
AOAS patients, mean age was significantly younger in men
than in women (22.0±5.9 vs 26.0±6.8, p=0.001). The pat-
tern of joint involvement was significantly different between
the two groups: the involvement of hand joints was more com-
mon in women. No significant difference in extra-articular
manifestation was found between men and women. There
was no significant difference in the laboratory findings be-
tween the two sexes.
Comparisons between JOAS and AOAS 
Nearly 85% of patients with JOAS had peripheral joint
disease, which contrasts with a figure of 61% found in AOAS
(p=0.00). Sixty percent of JOAS and 49% of AOAS patients
had peripheral enthesitis (p=0.028) (Table 4) . 
Comparisons between the patients with and without
peripheral arthritis
The age at onset in the patients with peripheral arthritis
was significantly younger than that in the patients without
peripheral arthritis. Patients with peripheral arthritis had a
higher frequency of enthesitis and trauma history. There was
no significant difference in the laboratory findings between
the two groups. 
Comparisons according to the presence of HLA B27
The relevant findings (data not shown) show similar sex
ratios, age at disease onset, duration of disease, and the pat-
tern of peripheral arthritis. The positivity of RF had not influ-
enced the peripheral arthritis and onset age. 
DISCUSSION
The present study was designed to describe the entire spec-
trum and to determine the frequencies of various articular
and extra-articular manifestations of AS. A total of 412 cases
of AS who satisfied the modified New York criteria (1) were
studied.
Despite the large number of patients, this study is essen-
tially limited by some features of its design; first, data was
collected retrospectively, second, the study was based on cases
referred to rheumatologic institutions, and third, it was fo-
cused on extraspinal symptoms including peripheral arthritis
due to limited data regarding spinal symptoms. These fac-
tors should be taken into consideration when interpreting
the results.
Demographic data of our patients showed similarities with
those of European patients. Khan found the mean age at onset
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Sacroiliac joints
Knee
Hip
Ankle
Heel
Tarsal
Shoulder
Plantar
Others
147 (36)  
112 (27)
62 (15)
29 (7)
29 (7)
9 (2)
8 (2)
4 (1)
14 (3)
Site Number (%) 
Table 2. The number of sites affected initially
Age at onset, years
Duration of disease (yr)
AOAS/JOAS
Peripheral arthritis
Knee
Ankle
Hand
Wrist
Elbow
Enthesitis
Family history of SpA
HLA B27
18.8±6.9
11.0±6.5
229/127
247 (69)
227 (64)
141 (39)
35 (14)
33 (13)
51 (21)
183 (51)
48 (13)
332 (93)
22.2±8.0
11.3±8.0
36/18
40 (73)
35 (64)
29 (53)
18 (33)
8 (16)
12 (22) 
34 (62)
9 (16)
53 (96)
0.001     
0.065  
0.00
p value Men (n=357, %) Women (n=55, %)
Table 3. Clinical presentations according to sex
Sex, M/F
Duration of disease (yr)
Enthesitis
Peripheral arthritis
Knee
Ankle
Elbow
Wrist
Hand
Shoulder
Hip
HLA B27
127/18
11.2±6.4
87 (60)
123 (85)
112 (77)
78 (54)
33 (23)
17 (12)
21 (14)
44
95
132 (91)
230/37
11.0±6.9
130 (49)
164 (61)
150 (56)
92 (34)
30 (11)
24 (9)
31 (12)
77
153
253 (95)
0.028     
0.00
0.00  
0.00  
0.001   
0.34
0.261 
p value JOAS (n=145, %) AOAS (n=267, %)
Table 4. Clinical presentations according to age at onsetto be 25 yr in AS, and reported that the onset after the age
of 45 was very uncommon (1). Another study reported the
mean age at onset to be the early twenties (7). The mean age
at onset in our patients was younger than Khan’s report by
almost 6 yr. One of the possible explanation might be the
relatively large number of JOAS included in our study. We
also noticed that AS is nine times more common in men than
in women, in contrast to the Khan’s report, which showed
that AS was three times more common in men. Although
the earlier estimated male-to-female ratio was 10-20:1, 5:1
has been accepted as a more likely ratio (8). Although racial
characteristics might have influenced the male predominance,
the male-to-female ratio in this study could be explained by
the followings. 1) Referral pattern may account for the scarce-
ness of women in our study, 2) the disease course of AS is
more benign in women and the radiologic progression is slow-
er in women than in men (5), 3) the young female patients
in their child-bearing ages were reluctant to have their repro-
ductive organs exposed to radiation, 4) had a high threshold
for seeking medical advice because they tend to regard back
pain or stiffness as somewhat insignificant physical signs in
their daily lives. Also, 5) a higher frequency of peripheral
arthritis among women could mislead to a diagnosis of rheu-
matoid arthritis.
We analyzed the differences in clinical manifestations be-
tween men and women. The average age at onset in women
was reported to be between 22 and 38 yr (4, 9, 10). Two re-
ports comparing men and women concluded that AS started
2 or 4 yr later in women (9, 10). Our data show that AS devel-
oped earlier in men than in women. Also, it is widely accept-
ed that women with AS more often exhibit arthritis in the
peripheral joints. Studies limited to female AS have demon-
strated a prevalence of peripheral arthritis ranging between
23% and 75% (9-11). A few clinical studies have reported a
significantly higher incidence of peripheral arthritis in women
(12-14). However, our study did not show any difference with
respect to the incidence of peripheral joint disease. Instead,
it showed a higher frequency of peripheral arthritis in men
as well as in women. However, we noticed that the patterns
of joint involvement were different: the hand joint involve-
ment was more common in women. Regarding the tests for
immune complexes, some investigators have detected circu-
lating immune complexes, while others have not. Khan re-
ported that the sex showed no association with either RF or
antinuclear antibody (1). In our study, RF was positive in 13%
of men and 9% of women, and however, the difference was
not statistically significant. Moreover, even if the RF was posi-
tive, the titer was low.
Patients in our study had a higher frequency of peripheral
joint involvement. Seventy percent of the patients experienced
signs and symptoms of peripheral joint involvement at some
time in their disease courses, often followed by the axial signs.
When only AOAS is taken into consideration, 61% of the
cases showed peripheral arthritis, which was more common
than Khan’s report. We found that there were some differences
in the clinical characteristics depending upon the presence
or absence of peripheral arthritis. Patients with peripheral
arthritis were younger and the age at the onset of disease was
younger than the patients without peripheral arthritis. They
also had higher frequencies of enthesitis and trauma history
prior to the onset of AS. 
To assess the influence of the age at onset, the clinical fea-
tures and other variables of JOAS patients were compared
with those of AOAS. This form of AS accounts for 10 to 21%
of Caucasian groups (1, 15, 16) but a significant proportion
of JOAS has been found in non-Caucasian groups from Africa,
Mexico, and India (15). We found JOAS is quite common.
A few previous studies have pointed out the influence at age
of onset on the clinical patterns of AS and have reported that
patients with a juvenile-onset usually have peripheral arthri-
tis, enthesitis, and systemic symptoms at onset, whereas pa-
tients with an adult-onset usually complain of back symptoms
and show objective signs of spinal and sacroiliac involvement
(1, 15, 16). Peripheral arthritis was a common finding in
our group, particularly among patients with a juvenile-onset. 
Another common feature of SpA is the familial aggrega-
tion, and it has been well documented that HLA B27 is close-
ly associated with the development of SpA (17-28). The pre-
valence of AS and related SpA seems to correlate directly with
that of HLA B27 in general population. When the entire
population of SpA was considered, HLA B27 was found to
be present in 50-90% of the patients (17-27). According to
another study that divided the study group into AS and non-
AS SpA, HLA B27 was present in 70.5% and 44.9%, respec-
tively (20). The HLA B27 antigen was positive in 93% of
our patients group. HLA B27 (+) patients were shown to have
an earlier onset of disease, a more severe clinical course, in-
creased frequencies of acute anterior uveitis and peripheral
arthritis (21-23). In our analysis, no difference was found in
the age at onset or the prevalences of peripheral joint involve-
ment and extra-articular manifestations between the HLA
B27 (+) and HLA B27 (-) groups.
Acute anterior uveitis, the most common extra-articular
involvement in patients with AS, is reported to occur in 1.5-
30% of patients, and is more common in HLA B27 (+) than
in HLA B27 (-) (1, 28-32). Also, there are several reports that
have shown the uveitis mostly affects male patients and the
classic features of AS are usually not present in the patients
with uveitis (28, 30). Uveitis was found in 22% and was
closely related with the male sex and HLA B27, however,
neither finding showed a statistical significance (data not
shown). 
The clinical features of our AS appears largely similar to
those in other studies, except a few noticeable differences: 1)
AS in our study was about nine times more common in men
than in women, as compared with Khan’s report, in which
AS was three times more common in men; 2) peripheral joint
involvement was more common in our study than in others;
672 J.-H. Lee, J.-B. Jun, S. Jung, et al.3) the pattern of joint involvement was significantly differ-
ent between men and women; the hand joint involvement
was more common in women; 4) JOAS was common in our
study; 5) the HLA B27 antigen frequency was 93% in our
study, which is higher than in others. 
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